CORONAVIRUS/COVID-19-induced thromboinflammation linked to CLEC2: NHRI
07/17/2023 06:49 PM
A new study by Taiwan's National Health Research Institute (NHRI) has identified a link between CLEC2, a C-type lectin-like type II transmembrane receptor, and thromboinflammation, the major cause of morbidity and mortality in COVID-19 patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
Taiwan to shorten COVID-19 vaccine interval to 2 months for high-risk groupsThe Centers for Disease Control (CDC) announced Thursday that the required interval between two COVID-19 vaccine doses for high-risk groups will be shortened from six months to two months, effective next Wednesday.06/06/2025 08:17 PM
CDC confirms ample supply of COVID-19 drugs, vaccinesThe Centers for Disease Control (CDC) reiterated Sunday that Taiwan has sufficient antiviral medication for COVID-19 patients and emphasized the importance of vaccination, amid concerns raised by public figures.06/01/2025 06:13 PM
CDC issues COVID-19 warning as Dragon Boat Festival long weekend beginsMembers of the public should not let their guard down on COVID-19 and seek medical help if they experience symptoms that indicate risk of severe infection, the Centers for Disease Control (CDC) said Friday, the first day of the Dragon Boat Festival long weekend in Taiwan.05/30/2025 05:04 PM
Latest
- Politics
China-Japan situation reflects 'wolf warrior' approach: Taiwan diplomat
12/15/2025 06:44 PM - Cross-Strait
Taiwan deeply regrets Jimmy Lai conviction under HK national security law
12/15/2025 06:13 PM - Business
Taiwan shares end sharply lower after U.S. losses amid AI bubble worries
12/15/2025 05:44 PM - Politics
Premier announces will not countersign revenue-allocation amendments
12/15/2025 05:25 PM - Politics
KMT asks prosecutors to look into MND defense contract award
12/15/2025 04:48 PM


